Evidence map›Paper›PMID 32479512›Full record

ArticlePloS one2020

Integration of phage and yeast display platforms: A reliable and cost effective approach for binning of peptides as displayed on-phage.

Priyanka Pandya, Robert O Sayers, Joey P Ting, Shaghayegh Morshedian, Carina Torres, Justine S Cudal, Kai Zhang, Jonathan R Fitchett, Qing Zhang, Feiyu F Zhang and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Biosynthetic Strategies for Macrocyclic Peptides.Molecules (Basel, Switzerland) · 2021
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Priyanka PandyaDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Robert O SayersDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Joey P TingDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Shaghayegh MorshedianDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Carina TorresDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Justine S CudalDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Kai ZhangDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Jonathan R FitchettDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Qing ZhangDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.
Feiyu F ZhangLilly Research Laboratories, Discovery Chemistry Research and Technologies, San Diego, California, United States of America.
Jing WangLilly Research Laboratories, Discovery Chemistry Research and Technologies, San Diego, California, United States of America.
Jim D DurbinDepartment of Structural Biology, Discovery Chemistry Research and Technologies, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
Juan J CarrilloDepartment of Quantitative Biology, Discovery Chemistry Research and Technologies, Lilly Biotechnology Center, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
Alfonso EspadaCentro de Investigación Lilly, Alcobendas, Spain.ORCID 0000-0002-8301-1201
Howard BroughtonCentro de Investigación Lilly, Alcobendas, Spain.
Yuewei QianLilly Research Laboratories, Recombinant Protein Generation, Indianapolis, Indiana, United States of America.
Sepideh AfsharDepartment of Protein Engineering, Eli Lilly Biotechnology Center, San Diego, California, United States of America.ORCID 0000-0002-9105-3946
Eli Lilly (United States) · USGEICAM – Spanish Breast Cancer Group · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hundreds of target specific peptides are routinely discovered by peptide display platforms. However, due to the high cost of peptide synthesis only a limited number of peptides are chemically made for further analysis. Here we describe an accurate and cost effective method to bin peptides on-phage based on binding region(s), without any requirement for peptide or protein synthesis. This approach, which integrates phage and yeast display platforms, requires display of target and its alanine variants on yeast. Flow cytometry was used to detect binding of peptides on-phage to the target on yeast. Once hits were identified, they were synthesized to confirm their binding region(s) by HDX (Hydrogen deuterium exchange) and crystallography. Moreover, we have successfully shown that this approach can be implemented as part of a panning process to deplete non-functional peptides. This technique can be applied to any target that can be successfully displayed on yeast; it narrows down the number of peptides requiring synthesis; and its utilization during selection results in enrichment of peptide population against defined binding regions on the target.

Indexed as

Peptide LibraryAlanineBacteriophagesCell Surface Display TechniquesCost-Benefit AnalysisFlow CytometryInterleukin-12 Subunit p40MutationProtein BindingRecombinant ProteinsReproducibility of ResultsSaccharomyces cerevisiaeAlanineIL12B protein, humanInterleukin-12 Subunit p40Peptide LibraryRecombinant Proteins

Identifiers

PMID32479512
PMCPMC7263589
OpenAlexW3031141621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.